• Record: found
  • Orcid: found
  • Profile: found

George Perry



    Distinguished as one of the top Alzheimer’s disease researchers with over 1000 publications, one of the top 100 most-cited scientists in neuroscience and behavior. Perry has been cited over 122,000 times (H=174) and is recognized as an ISI highly cited researcher. Perry is editor for numerous journals and is Editor-in-Chief for the Journal of Alzheimer's Disease. He is a Fellow of the American Association for the Advancement of Sciences, Sigma Xi, Microscopy Society of America, International Engineering and Technology Institute, Texas Academy of Sciences, Association of Biotechnology and Pharmacy (FABAP), Royal Society of Chemistry (FRSC, CChem), Royal Society of Medicine, Royal College of Pathologists (FRCPath), Royal Society for the encouragement of Arts, Manufacturers and Commerce (FRSA), Royal Society of Biology (FRSB, CBio, CSci, CSciTeach), Linnean Society of London (FLS), Royal Microscopical Society (FRMS), World Academy of Medical Sciences (FWAMS), EU Academy of Sciences, past-president of the American Association of Neuropathologists and the Southwestern and Rocky Mountain Division of the American Association for the Advancement of Science, Foreign Correspondent Member of the Spanish Royal Academy of Sciences, Foreign Corresponding Member of the Academy of Sciences of Lisbon, Corresponding member of the Mexican Academy of Sciences, Doctorado Honoris Causa (Hon. D.)-Universidad Arturo Prat, Iquique, Chile, and member of the Iberoamerican Molecular Biology Organization, the Conselho da Diáspora Portuguesa and Real Ordem Equestre e Militar de São Miguel da Ala . He won the Distinguished Professional Mentor award from the Society for the Advancement of Chicanos and Native Americans in Sciences, Senior Investigator Award-International College of Geriatric Psychoneuropharmacology, Honorable Director-Global Listening Centre, Martin Goland Award- Alamo Chapter Sigma Xi, UDAAN-Lifetime Achievement Award, Top Specialist in Alzheimer disease- Expertscape, Albert Nelson Marquis Lifetime Achievement Award- Marquis Who's Who, International Engineering and Technology Institute-Annual Scientific Award 2017, Denham Harman Award-American Aging Association, Zenith Award and Temple Award-Alzheimer Association, Mensch Award-Alzheimer Research Forum, Notaveis dos Azores, Scientist of the Year-Portuguese Tribune, Senior Fulbright Fellow, Distinguished Texas Scientist-Texas Academy of Sciences, Distinguished Member-Japanese Society of Neurology, Rous-Whipple Award-American Society for Investigative Pathology, Scientist of the Year 2021-BioPub, Best Scientist 2022-Research.com, Research and Education Lifetime Achievement Award-Global Association for the Study of Neurodegenerative Diseases, Golden Axon Leadership Award-World Brain Mapping Foundation and the Panama National Plaque of Honor for Excellence in Neuroscience.

    Perry's research is primarily focused on how Alzheimer disease develops and the physiological consequences of the disease at a cellular level. He is currently working to determine the sequence of events leading to damage caused by and the source of metabolic abnormalities.


    University of Texas at San Antonio

    Neuroscience, Development and Regenerative Biology (formerly Biology)

    University of Texas at San Antonio


    Case Western Reserve University School of Medicine



    Baylor College of Medicine, Cell Biology

    University of California San Diego Scripps Institution of Oceanography, Marine Biology

    Hopkins Marine Station, Stanford University

    Marine Biological Laboratory, Embryology

    University of California Santa Barbara, Biology

    Allan Hancock College, Liberal Arts

    Self description

    All of Dr. Perry’s research is centered around Neurodegeneration. In particular, Dr. Perry focuses mostly on Alzheimer’s disease and the effects of oxidative stress on the disease as well as its effects on other neurodegenerative disorders.